ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,027, issued on Nov. 3, was assigned to INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES (Beijing).
"C-terminally modified human papillomavirus type 11 L1 protein and use thereof" was invented by Xuemei Xu (Beijing), Ting Zhang (Beijing) and Baicheng Xia (Beijing).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to a C-terminus modified human papillomavirus type 11 L1 protein and the use thereof. Specifically, the present application relates to a C-terminus modified human papillomavirus (HPV) type 11 L1 protein, a nucleotide encoded thereby, a vector containing the nucleotide, a cell containing the ...